nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftaroline fosamil—Transaminases increased—Progesterone—uterine cancer	0.0328	0.0328	CcSEcCtD
Ceftaroline fosamil—Phlebitis—Carboplatin—uterine cancer	0.032	0.032	CcSEcCtD
Ceftaroline fosamil—Hyperkalaemia—Medroxyprogesterone Acetate—uterine cancer	0.0178	0.0178	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Medroxyprogesterone Acetate—uterine cancer	0.0119	0.0119	CcSEcCtD
Ceftaroline fosamil—Phlebitis—Dactinomycin—uterine cancer	0.0119	0.0119	CcSEcCtD
Ceftaroline fosamil—Pain—Carboplatin—uterine cancer	0.0116	0.0116	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Progesterone—uterine cancer	0.0113	0.0113	CcSEcCtD
Ceftaroline fosamil—Infestation—Progesterone—uterine cancer	0.0112	0.0112	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Progesterone—uterine cancer	0.0112	0.0112	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Carboplatin—uterine cancer	0.0107	0.0107	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Progesterone—uterine cancer	0.0106	0.0106	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.0102	0.0102	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Medroxyprogesterone Acetate—uterine cancer	0.0101	0.0101	CcSEcCtD
Ceftaroline fosamil—Infestation—Medroxyprogesterone Acetate—uterine cancer	0.0101	0.0101	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Progesterone—uterine cancer	0.01	0.01	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Progesterone—uterine cancer	0.00989	0.00989	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Progesterone—uterine cancer	0.00982	0.00982	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Medroxyprogesterone Acetate—uterine cancer	0.00956	0.00956	CcSEcCtD
Ceftaroline fosamil—Transaminases increased—Epirubicin—uterine cancer	0.0094	0.0094	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.00924	0.00924	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Progesterone—uterine cancer	0.00909	0.00909	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.00908	0.00908	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Progesterone—uterine cancer	0.00905	0.00905	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Medroxyprogesterone Acetate—uterine cancer	0.00897	0.00897	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Medroxyprogesterone Acetate—uterine cancer	0.0089	0.0089	CcSEcCtD
Ceftaroline fosamil—Erythema—Progesterone—uterine cancer	0.00872	0.00872	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Progesterone—uterine cancer	0.00872	0.00872	CcSEcCtD
Ceftaroline fosamil—Transaminases increased—Doxorubicin—uterine cancer	0.0087	0.0087	CcSEcCtD
Ceftaroline fosamil—Phlebitis—Etoposide—uterine cancer	0.0086	0.0086	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Dactinomycin—uterine cancer	0.00827	0.00827	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.00824	0.00824	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.0082	0.0082	CcSEcCtD
Ceftaroline fosamil—Anaemia—Progesterone—uterine cancer	0.00806	0.00806	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.0079	0.0079	CcSEcCtD
Ceftaroline fosamil—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.0079	0.0079	CcSEcCtD
Ceftaroline fosamil—Palpitations—Progesterone—uterine cancer	0.00771	0.00771	CcSEcCtD
Ceftaroline fosamil—Convulsion—Progesterone—uterine cancer	0.00756	0.00756	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00737	0.00737	CcSEcCtD
Ceftaroline fosamil—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.0073	0.0073	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Progesterone—uterine cancer	0.00712	0.00712	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Dactinomycin—uterine cancer	0.00708	0.00708	CcSEcCtD
Ceftaroline fosamil—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00698	0.00698	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Progesterone—uterine cancer	0.00698	0.00698	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Progesterone—uterine cancer	0.00691	0.00691	CcSEcCtD
Ceftaroline fosamil—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00685	0.00685	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00668	0.00668	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00645	0.00645	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00633	0.00633	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00632	0.00632	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00627	0.00627	CcSEcCtD
Ceftaroline fosamil—Erythema—Dactinomycin—uterine cancer	0.00616	0.00616	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Progesterone—uterine cancer	0.00615	0.00615	CcSEcCtD
Ceftaroline fosamil—Constipation—Progesterone—uterine cancer	0.00609	0.00609	CcSEcCtD
Ceftaroline fosamil—Pain—Progesterone—uterine cancer	0.00609	0.00609	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Etoposide—uterine cancer	0.00599	0.00599	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Progesterone—uterine cancer	0.00582	0.00582	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Etoposide—uterine cancer	0.00571	0.00571	CcSEcCtD
Ceftaroline fosamil—Infestation—Etoposide—uterine cancer	0.00571	0.00571	CcSEcCtD
Ceftaroline fosamil—Anaemia—Dactinomycin—uterine cancer	0.0057	0.0057	CcSEcCtD
Ceftaroline fosamil—Urticaria—Progesterone—uterine cancer	0.00565	0.00565	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Progesterone—uterine cancer	0.00563	0.00563	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Progesterone—uterine cancer	0.00563	0.00563	CcSEcCtD
Ceftaroline fosamil—Hyperkalaemia—Epirubicin—uterine cancer	0.00562	0.00562	CcSEcCtD
Ceftaroline fosamil—Renal failure—Etoposide—uterine cancer	0.00561	0.00561	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00557	0.00557	CcSEcCtD
Ceftaroline fosamil—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00552	0.00552	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Etoposide—uterine cancer	0.0054	0.0054	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00527	0.00527	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Progesterone—uterine cancer	0.00524	0.00524	CcSEcCtD
Ceftaroline fosamil—Hyperkalaemia—Doxorubicin—uterine cancer	0.0052	0.0052	CcSEcCtD
Ceftaroline fosamil—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00512	0.00512	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.0051	0.0051	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.0051	0.0051	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Etoposide—uterine cancer	0.00506	0.00506	CcSEcCtD
Ceftaroline fosamil—Pruritus—Progesterone—uterine cancer	0.00504	0.00504	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Etoposide—uterine cancer	0.00502	0.00502	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Dactinomycin—uterine cancer	0.00493	0.00493	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Progesterone—uterine cancer	0.00487	0.00487	CcSEcCtD
Ceftaroline fosamil—Phlebitis—Epirubicin—uterine cancer	0.00482	0.00482	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00475	0.00475	CcSEcCtD
Ceftaroline fosamil—Dizziness—Progesterone—uterine cancer	0.00471	0.00471	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Etoposide—uterine cancer	0.00465	0.00465	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Etoposide—uterine cancer	0.00463	0.00463	CcSEcCtD
Ceftaroline fosamil—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00456	0.00456	CcSEcCtD
Ceftaroline fosamil—Vomiting—Progesterone—uterine cancer	0.00453	0.00453	CcSEcCtD
Ceftaroline fosamil—Rash—Progesterone—uterine cancer	0.00449	0.00449	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Progesterone—uterine cancer	0.00448	0.00448	CcSEcCtD
Ceftaroline fosamil—Phlebitis—Doxorubicin—uterine cancer	0.00446	0.00446	CcSEcCtD
Ceftaroline fosamil—Headache—Progesterone—uterine cancer	0.00446	0.00446	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00441	0.00441	CcSEcCtD
Ceftaroline fosamil—Pain—Dactinomycin—uterine cancer	0.0043	0.0043	CcSEcCtD
Ceftaroline fosamil—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00427	0.00427	CcSEcCtD
Ceftaroline fosamil—Nausea—Progesterone—uterine cancer	0.00423	0.00423	CcSEcCtD
Ceftaroline fosamil—Anaemia—Etoposide—uterine cancer	0.00412	0.00412	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00411	0.00411	CcSEcCtD
Ceftaroline fosamil—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.0041	0.0041	CcSEcCtD
Ceftaroline fosamil—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00407	0.00407	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00406	0.00406	CcSEcCtD
Ceftaroline fosamil—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00404	0.00404	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Dactinomycin—uterine cancer	0.00398	0.00398	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Dactinomycin—uterine cancer	0.00398	0.00398	CcSEcCtD
Ceftaroline fosamil—Convulsion—Etoposide—uterine cancer	0.00387	0.00387	CcSEcCtD
Ceftaroline fosamil—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00383	0.00383	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Epirubicin—uterine cancer	0.00378	0.00378	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00377	0.00377	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Dactinomycin—uterine cancer	0.00371	0.00371	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Etoposide—uterine cancer	0.00364	0.00364	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Etoposide—uterine cancer	0.00357	0.00357	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Epirubicin—uterine cancer	0.00355	0.00355	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Etoposide—uterine cancer	0.00354	0.00354	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Doxorubicin—uterine cancer	0.0035	0.0035	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Dactinomycin—uterine cancer	0.00344	0.00344	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Epirubicin—uterine cancer	0.00336	0.00336	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Doxorubicin—uterine cancer	0.00329	0.00329	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Epirubicin—uterine cancer	0.00324	0.00324	CcSEcCtD
Ceftaroline fosamil—Infestation—Epirubicin—uterine cancer	0.0032	0.0032	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Epirubicin—uterine cancer	0.0032	0.0032	CcSEcCtD
Ceftaroline fosamil—Vomiting—Dactinomycin—uterine cancer	0.0032	0.0032	CcSEcCtD
Ceftaroline fosamil—Rash—Dactinomycin—uterine cancer	0.00317	0.00317	CcSEcCtD
Ceftaroline fosamil—Renal failure—Epirubicin—uterine cancer	0.00315	0.00315	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Etoposide—uterine cancer	0.00314	0.00314	CcSEcCtD
Ceftaroline fosamil—Pain—Etoposide—uterine cancer	0.00311	0.00311	CcSEcCtD
Ceftaroline fosamil—Constipation—Etoposide—uterine cancer	0.00311	0.00311	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Doxorubicin—uterine cancer	0.00311	0.00311	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Epirubicin—uterine cancer	0.00303	0.00303	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Doxorubicin—uterine cancer	0.003	0.003	CcSEcCtD
Ceftaroline fosamil—Nausea—Dactinomycin—uterine cancer	0.00299	0.00299	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Etoposide—uterine cancer	0.00298	0.00298	CcSEcCtD
Ceftaroline fosamil—Infestation—Doxorubicin—uterine cancer	0.00296	0.00296	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Doxorubicin—uterine cancer	0.00296	0.00296	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Epirubicin—uterine cancer	0.00292	0.00292	CcSEcCtD
Ceftaroline fosamil—Renal failure—Doxorubicin—uterine cancer	0.00291	0.00291	CcSEcCtD
Ceftaroline fosamil—Urticaria—Etoposide—uterine cancer	0.00289	0.00289	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Etoposide—uterine cancer	0.00288	0.00288	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Etoposide—uterine cancer	0.00288	0.00288	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Epirubicin—uterine cancer	0.00287	0.00287	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Epirubicin—uterine cancer	0.00284	0.00284	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Epirubicin—uterine cancer	0.00282	0.00282	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Doxorubicin—uterine cancer	0.0028	0.0028	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Doxorubicin—uterine cancer	0.00271	0.00271	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Etoposide—uterine cancer	0.00268	0.00268	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Doxorubicin—uterine cancer	0.00266	0.00266	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Doxorubicin—uterine cancer	0.00263	0.00263	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Epirubicin—uterine cancer	0.00261	0.00261	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Doxorubicin—uterine cancer	0.00261	0.00261	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Epirubicin—uterine cancer	0.0026	0.0026	CcSEcCtD
Ceftaroline fosamil—Pruritus—Etoposide—uterine cancer	0.00258	0.00258	CcSEcCtD
Ceftaroline fosamil—Erythema—Epirubicin—uterine cancer	0.0025	0.0025	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Epirubicin—uterine cancer	0.0025	0.0025	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Etoposide—uterine cancer	0.00249	0.00249	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Doxorubicin—uterine cancer	0.00241	0.00241	CcSEcCtD
Ceftaroline fosamil—Dizziness—Etoposide—uterine cancer	0.00241	0.00241	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Doxorubicin—uterine cancer	0.0024	0.0024	CcSEcCtD
Ceftaroline fosamil—Vomiting—Etoposide—uterine cancer	0.00232	0.00232	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Doxorubicin—uterine cancer	0.00231	0.00231	CcSEcCtD
Ceftaroline fosamil—Erythema—Doxorubicin—uterine cancer	0.00231	0.00231	CcSEcCtD
Ceftaroline fosamil—Anaemia—Epirubicin—uterine cancer	0.00231	0.00231	CcSEcCtD
Ceftaroline fosamil—Rash—Etoposide—uterine cancer	0.0023	0.0023	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Etoposide—uterine cancer	0.00229	0.00229	CcSEcCtD
Ceftaroline fosamil—Headache—Etoposide—uterine cancer	0.00228	0.00228	CcSEcCtD
Ceftaroline fosamil—Palpitations—Epirubicin—uterine cancer	0.00221	0.00221	CcSEcCtD
Ceftaroline fosamil—Convulsion—Epirubicin—uterine cancer	0.00217	0.00217	CcSEcCtD
Ceftaroline fosamil—Nausea—Etoposide—uterine cancer	0.00216	0.00216	CcSEcCtD
Ceftaroline fosamil—Anaemia—Doxorubicin—uterine cancer	0.00214	0.00214	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.00211	0.00211	CcSEcCtD
Ceftaroline fosamil—Palpitations—Doxorubicin—uterine cancer	0.00204	0.00204	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Epirubicin—uterine cancer	0.00204	0.00204	CcSEcCtD
Ceftaroline fosamil—Convulsion—Doxorubicin—uterine cancer	0.002	0.002	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Epirubicin—uterine cancer	0.002	0.002	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Epirubicin—uterine cancer	0.002	0.002	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Epirubicin—uterine cancer	0.00198	0.00198	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.00196	0.00196	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Doxorubicin—uterine cancer	0.00189	0.00189	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Doxorubicin—uterine cancer	0.00185	0.00185	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Doxorubicin—uterine cancer	0.00185	0.00185	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Doxorubicin—uterine cancer	0.00183	0.00183	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Epirubicin—uterine cancer	0.00176	0.00176	CcSEcCtD
Ceftaroline fosamil—Pain—Epirubicin—uterine cancer	0.00175	0.00175	CcSEcCtD
Ceftaroline fosamil—Constipation—Epirubicin—uterine cancer	0.00175	0.00175	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Epirubicin—uterine cancer	0.00167	0.00167	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.00163	0.00163	CcSEcCtD
Ceftaroline fosamil—Urticaria—Epirubicin—uterine cancer	0.00162	0.00162	CcSEcCtD
Ceftaroline fosamil—Pain—Doxorubicin—uterine cancer	0.00162	0.00162	CcSEcCtD
Ceftaroline fosamil—Constipation—Doxorubicin—uterine cancer	0.00162	0.00162	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Epirubicin—uterine cancer	0.00161	0.00161	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Epirubicin—uterine cancer	0.00161	0.00161	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Doxorubicin—uterine cancer	0.00154	0.00154	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Epirubicin—uterine cancer	0.0015	0.0015	CcSEcCtD
Ceftaroline fosamil—Urticaria—Doxorubicin—uterine cancer	0.0015	0.0015	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Doxorubicin—uterine cancer	0.00149	0.00149	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Doxorubicin—uterine cancer	0.00149	0.00149	CcSEcCtD
Ceftaroline fosamil—Pruritus—Epirubicin—uterine cancer	0.00144	0.00144	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Epirubicin—uterine cancer	0.0014	0.0014	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Doxorubicin—uterine cancer	0.00139	0.00139	CcSEcCtD
Ceftaroline fosamil—Dizziness—Epirubicin—uterine cancer	0.00135	0.00135	CcSEcCtD
Ceftaroline fosamil—Pruritus—Doxorubicin—uterine cancer	0.00134	0.00134	CcSEcCtD
Ceftaroline fosamil—Vomiting—Epirubicin—uterine cancer	0.0013	0.0013	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Doxorubicin—uterine cancer	0.00129	0.00129	CcSEcCtD
Ceftaroline fosamil—Rash—Epirubicin—uterine cancer	0.00129	0.00129	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Epirubicin—uterine cancer	0.00129	0.00129	CcSEcCtD
Ceftaroline fosamil—Headache—Epirubicin—uterine cancer	0.00128	0.00128	CcSEcCtD
Ceftaroline fosamil—Dizziness—Doxorubicin—uterine cancer	0.00125	0.00125	CcSEcCtD
Ceftaroline fosamil—Nausea—Epirubicin—uterine cancer	0.00121	0.00121	CcSEcCtD
Ceftaroline fosamil—Vomiting—Doxorubicin—uterine cancer	0.0012	0.0012	CcSEcCtD
Ceftaroline fosamil—Rash—Doxorubicin—uterine cancer	0.00119	0.00119	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Doxorubicin—uterine cancer	0.00119	0.00119	CcSEcCtD
Ceftaroline fosamil—Headache—Doxorubicin—uterine cancer	0.00118	0.00118	CcSEcCtD
Ceftaroline fosamil—Nausea—Doxorubicin—uterine cancer	0.00112	0.00112	CcSEcCtD
